In Brief: Boston Scientific/Scimed
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific/Scimed: Federal Trade Commission requests additional information from the two companies regarding their proposed $865 mil. stock swap merger, which was announced in November ("The Gray Sheet" Nov. 14, 1994, p. 12). The additional information pertains to "the activities of the two companies in the area of intravascular ultrasound," the firms say in a joint statement. In September, Boston Scientific entered a definitive agreement to acquire IVUS system manufacturer Cardiovascular Imaging Systems in a deal valued at about $100 mil. Both Boston Scientific and Scimed have also been developing IVUS technology. The companies say that the FTC request is "not unusual for this type of transaction"...